The Berlin/Boston-based startup is building vascularised tissue today, with a long-term ambition to manufacture fully ...

Funding will accelerate preclinical validation of biofabricated tissue implants for soft tissue repair, wound healing and trauma care - while building the biological and manufacturing foundations for ...

This is why the new funding matters. It allows Cellbricks Therapeutics to move beyond promise and into proof: to show that ...

BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization ...

Q4 2025 Earnings Call March 25, 2026 4:30 PM EDTCompany ParticipantsMichael Handley - CEO & DirectorLisa Wolf - ...

Japan’s move to conditionally approve two induced pluripotent stem cell derived therapies marks a significant development for ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

There is no better advert for an electric car than waiting for hours in a tense queue for rationed fuel. Read more at ...

Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028A 'truly transformative' ...

Researchers have developed a new lipid nanoparticle design that directs mRNA to the pancreas by exploiting the organ’s own ...